Long-term differentiated function of heterotopically transplanted hepatocytes on three-dimensional polymer matrices

Journal of Biomedical Materials Research

Volumn 47, Issue 4, 1997, Pages 494-503

  Kneser, Ulrich ^a   Kaufmann, Peter M ^a   Fiegel, Henning C ^a   Pollok, Joerg M ^a   Kluth, Dietrich ^a   Herbst, Hermann ^a   Rogiers, Xavier ^a  

^a UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

Author keywords

Cell polymer constructs; Hepatic tissue engineering; Hepatocyte transplantation; In situ hybridization

Indexed keywords

BIOMEDICAL ENGINEERING; CELLS; DISEASES; FUNCTIONAL ASSESSMENT; GRAFTS; IMPLANTS (SURGICAL); PHYSICAL THERAPY; TISSUE;

CRIGLER-NAJJAR SYNDROME; ENGRAFTMENT; HEPATIC TISSUE ENGINEERING; HEPATOCYTE; LIVER FAILURE;

TRANSPLANTATION (SURGICAL);

ACTIN; ALBUMIN; CYTOKERATIN; DESMIN; POLYMER; POLYVINYL ALCOHOL; RNA;

ANIMAL CELL; ARTICLE; CELL COUNT; CELL DIFFERENTIATION; CELL FUNCTION; CELL STIMULATION; CELL TRANSPLANTATION; CONTROLLED STUDY; IMMUNOHISTOLOGY; LIVER CELL; MALE; MORPHOMETRICS; NONHUMAN; PORTOCAVAL SHUNT; RAT; XENOTRANSPLANTATION;

EID: 0031573495     PISSN: 00219304     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-4636(19991215)47:4<494::AID-JBM5>3.0.CO;2-L     Document Type: Article

References (40)

1. Starzel TE, Demetris AJ, Van Thiel D. Chronic liver failure: orthotopic liver transplantation. N Engl J Med 1989;321:1014-1022.
2. Harper AM, Rosendale JD. The UNOS OPTN waiting list and donor registry: 1988-1996. Clin Transplant 1996;69-90.
3. Moehler M, Wagner V, Stremmel W. Heriditaere lebererkrankungen. Dtsch Med Wochenschr 1998;123:466-471.
4. Asonuma K, Gilbert JG, Stein JE, Takeda T, Vacanti JP. Quantification of transplanted hepatic mass necessary to cure the Gunn rat model of hyperbilirubinemia. J Pediatr Surg 1992;27: 298-301.
5. Hughes RD, Williams R. Use of bioartificial and artificial liver support devices. Sem Liver Disease 1996;16:435-444.
6. Gerlach JC, Encke J, Hole O, Muller C, Ryan CJ, Neuhaus P. Bioreactor for a larger scale hepatocyte in vitro perfusion. Transplantation 1994;58:984-988.
7. Watanabe FD, Mullon CJP, Hewitt WR, Arkadopolus N, Kahaku E, Eguchi S, Khalili T, Arnaout W, Shackleton CR, Rozga J, Solomon B, Demetriou AA. Clinical experience with a bioartificial liver in the treatment of severe liver failure. Ann Surg 1997;225:484-494.
8. Mito M, Ebata H, Kusano M, Onishi T, Saito T, Sakamoto S. Morphology and function of isolated hepatocytes transplanted into rat spleen. Transplantation 1979;28:499-505.
9. Xiangdong W, Ar'Rajab A, Ahren B, Andersson R, Bengmark S. The effect of pancreatic islets on transplanted hepatocytes in the treatment of acute liver failure in rats. Res Exp Med Berl 1992;191:429-435.
10. Demetriou AA, Whiting JF, Feldman D, Levenson SM, Chowdhury NR, Moscioni AD, Kram M, Chowdhury JR. Replacement of liver function in rats by transplantation of microcarrier-attached hepatocytes. Science 1986;233(4769):1190-1192.
11. Holzman MD, Rozga J, Neuzil DF, Griffin D, Moscioni AD, Demetriou AA. Selective intraportal hepatocyte transplantation in analbuminemic and Gunn rats. Transplantation 1993; 55:1213-1219.
12. Fox IJ, Chowdhury JR, Kaufman SS, Goertzen TC, Chowdhury NR, Warkentin PI, Dorko K, Sauter BV, Strom SC. Treatment of the Crigler-Najjar syndrome type 1 with hepatocyte transplantation. N Engl J Med 1998;338:1422-1426.
13. Nieto JA, Escandon J, Betancor C, Ramos J, Canton C, Cuervas-Mons V. Evidence that temporary complete occlusion of splenic vessels prevents massive embolization and sudden death associated with intrasplenic hepatocellular transplantation. Transplantation 1989;47:449-150.
14. Benedetti E, Kirby JP, Asolati M, Blanchard J, Ward MG, Williams R, Hewett TA, Fontaine M, Pollak R. Intrasplenic hepatocyte allo-transplantation in Dalmatian dogs with and without cyclosporine immunosuppression. Transplantation 1997; 63:1206-1209.
15. Ingber DE. Extracellular matrix and the development of tissue architecture: a mechanochemical perspective. In: Zern MA, Reid LM, editors. Extracellular matrix. New York: Marcel Dekker; 1993. p 403-428.
16. Langer R, Vacanti JP. Tissue engineering. Science 1993; 260(5110):920-926.
17. Uyama S, Kaufmann PM, Takeda T, Vacanti JP. Delivery of whole liver-equivalent hepatocyte mass using polymer devices and hepatotrophic stimulation. Transplantation 1993;55(4): 932-935.
18. Mooney D, Hansen L, Vacanti JP, Langer R, Farmer S, Ingber D. Switching from differentiation to growth in hepatocytes: control by extracellular matrix. J Cell Physiol 1992;151:497-505.
19. Hkrach JS, Ou J, Lothan N, Langer R. Poly(L-lactic acid-co-aspartic acid): interactive polymers for tissue engineering. In: Mikos AG, Leong KW, Yaszemski MJ, Tamada JA, Radomsky ML, editors. Polymers in medicine and pharmacy. Symposium Proceedings 394. Pittsburgh, PA: Materials Research Society; 1995. p 77-82.
20. Gilbert JC, Takeda T, Stein JE, Langer R, Vacanti JP. Cell transplantation of genetically altered cells on biodegradable polymer scaffolds in syngenic rats. Transplantation 1995;56:423-427.
21. Wake CM, Mikos AG, Sarakinos G, Vacanti JP, Langer R. Dynamics of fibrovascular tissue ingrowth in hydrogel foams. Cell Transplant 1995;4:275-279.
22. Kaufmann PM, Sano K, Uyama S, Takeda T, Vacanti JP. Heterotopic hepatocyte transplantation: assessing the impact of hepatotrophic stimulation. Transplant Proc 1994;26:2240-2241.
23. Starzel TE, Francavilla A, Halgrimson CG, Francavilla FR, Porter KA, Brown TH, Putnam CW. The origin, hormonal nature, and action of hepatotrophic substances in portal venous blood. Surg Gynecol Obstet 1973;137:179-199.
24. Kaufmann PM, Sano K, Uyama S, Schloo B, Vacanti JP. Heterotopic hepatocyte transplantation using three-dimensional polymers: evalution of the stimulatory effects by portocaval shunt or islet cell cotransplantation. Transplant Proc 1994;26: 343-345.
25. Johnson LB, Aiken J, Mooney D, Schloo BL, Griffith-Cima L, Langer R, Vacanti JP. The mesentery as a laminated vascular bed for hepatocyte transplantation. Cell Transplant 1994;3:273-281.
26. Mooney DJ, Sano K, Kaufmann PM, Majahod K, Schloo B, Vacanti JP, Langer R. Long-term engraftment of hepatocytes transplanted on biodegradable polymer sponges. J Biomed Mater Res 1997;37:413-420.
27. Lee SH, Fisher B. Portocaval shunt in the rat. Surgery 1961;50: 668.
28. Seglen PO. Preparation of isolated rat liver cells. Methods Cell Biol 1976;13:29-83.
29. Stein H, Gatter K, Asbahr H, Maosn DY. Use of freeze dried paraffin-embedded sections for immunohistologic staining with monoclonal antibodies. Lab Invest 1985;52:676-683.
30. Herbst H, Wege T, Milani S, Grappone G, Orzechowski HD, Bechstein WO, Neuhaus P, Gressner AM, Schuppan D. Tissue inhibitor of metalloproteinases-1 and -2 expression in rat and human liver fibrosis. Am J Pathol 1997;150:1647-1659.
31. Sargent TD, Yang M, Bonner J. Nucleotide sequence of cloned rat serum albumin messenger RNA. Proc Natl Acad Sci USA 1981;78:243-246.
32. Milani S, Herbst H, Schuppan D, Hahn EG, Stein H. In situ hybridization for procollagen types I, III, and IV mRNA in normal and fibrotic rat liver. Hepatology 1989;10:84-92.
33. Elcin YM, Dixit V, Gitnick G. Controlled release of endothelial cell growth factor from chitosan-albumin microspheres for localized angiogenesis: in vitro and in vivo studies. Artif Cells Blood Substit Immobil Biotechnol 1996;24:257-271.
34. Kaufmann PM, Kneser U, Fiegel HC, Pollok JM, Kluth D, Izbicki JR, Herbst H, Rogiers X. Is there an optimal concentration of co-transplanted islets of Langerhans for stimulation of hepatocytes on three-dimensional matrices? Transplantation. To appear.
35. Mooney DJ, Kaufmann PM, Sano K, Schwendemann SP, Majahood K, Schloo B, Vacanti JP, Langer R. Localized delivery of epidermal growth factor improves the survival of transplanted hepatocytes. Biotechnol Bioeng 1996;50:422-429.
36. Sano K, Cusick RA, Lee H, Pollok JM, Kaufmann PM, Uyama S, Langer R, Vacanti ZP. Regenerative signals for heterotopic hepatocyte transplantation. Transplant Proc 1996;28:1857-1858.
37. Yokoi Y, Namishima T, Kuroda H, Komatsu I, Miyazaki A, Watanabe S, Usui K. Immunocytochemical detection of desmin in fat-storing cells (Ito cells). Hepatology 1984;4:709-714.
38. Ballardini G, Fallani M, Biagini G, Bianch FB, Pisi E. Desmin and actin in the identification of Ito cells and in monitoring their evolution to myofibroblasts in experimental liver fibrosis. Virchows Arch B Cell Pathol 1988;56:45-49.
39. Schuppan D, Herbst H, Milani S. Matrix, matrix synthesis and molecular networks in hepatic fibrosis. In: Zern MA, Reid LM, editors. Extracellular matrix. New York: Marcel Dekker; 1993. p 201-254.
40. Mooney DJ, Park S, Kaufmann PM, Sano K, McNamara K, Vacanti JP, Langer R. Biodegradable sponges for hepatocyte transplantation. J Biomed Mater Res 1995;29:959-965.